Short answer
Definitive Healthcare Corp. (DH) filed its Q2 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $55M (down 9.1% year over year) with net income of −$5M.
Q2 2026 key financials · XBRL
- Revenue
- $55M
- −9.1% YoY · −1.3% QoQ
- Net income
- −$5M
- +28.2% YoY · +96.1% QoQ
- Operating margin
- -12.2%
- Gross margin
- 73.5%
- EPS (diluted)
- −$0.05
- +50.0% YoY · +96.2% QoQ
Source: XBRL data from the Definitive Healthcare Corp. (DH) Q2 2026 10-Q on SEC EDGAR. USD.
Definitive Healthcare Corp. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $55.195M, down 9% YoY from $60.750M, driven by lower subscription and professional services revenue
- Gross profit $40.541M versus $46.613M YoY; gross margin 73.4% versus 76.7%
- Operating loss $6.748M versus $4.170M YoY; operating margin (12.2%) versus (6.9%)
- Customer count approximately 2,200 versus 2,400 YoY; Enterprise Customers 477 versus 510
- Outlook: negative revenue growth in 2026, pressured by churn, elongated deal cycles, and sales execution challenges; Turbo pilot begins in the third quarter
Risk Factors
- Newly added Nasdaq compliance risk triggered by bid price below $1.00 for 30 consecutive business days
- Delisting deadline December 15, 2026, requiring $1.00 closing bid for 10 consecutive business days
- Delisting could reduce trading liquidity, depress share price, and constrain capital-raising ability
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Definitive Healthcare Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.